Vilacto Bio Inc. — key financial figures for fiscal year 2018 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2018)

$4.9K

Net Income/Loss (FY2018)

-$7.9M

Total Assets (FY2018)

$537.7K

Total Equity (FY2018)

-$3.4M

Cash Flows from Operating Activities (FY2018)

-$601.2K

Source: Vilacto Bio Inc. 10-K filing (FY2018). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.